By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Regeneron Pharmaceuticals, Inc. 

777 Old Saw Mill River Road

Tarrytown  New York  10591  U.S.A.
Phone: 914-847-7000 Fax: n/a


SEARCH JOBS



Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma, and atopic dermatitis.

Visit our website – www.regeneron.com
Check out our openings – http://careers.regeneron.com


Key Statistics


Email:
Ownership: Public

Web Site: Regeneron
Employees: 2300+
Symbol: REGN
 





Collaborations

Sanofi US 

Bayer 

Geisinger Health System  Collaboration with Regeneron Genetics Center LLC, wholly-owned subsidiary of Regeneron.

Avalanche Biotech 





Company News
Regeneron (REGN) Reports Fourth Quarter And Full Year 2016 Financial And Operating Results 2/9/2017 9:45:23 AM
Regeneron (REGN) To Report Fourth Quarter And Full Year 2016 Financial And Operating Results And Host Conference Call And Webcast On February 9, 2017 2/7/2017 10:08:34 AM
Here Are 5 Tricky Job Interview Questions You Might Get at Genentech (RHHBY), Regeneron (REGN), and Stratos 2/2/2017 3:01:06 PM
Regeneron (REGN) And Sanofi (SNY) Announce First Approval Of Kevzara (Sarilumab) For The Treatment Of Moderately To Severely Active Rheumatoid Arthritis In Adult Patients By Health Canada 2/1/2017 7:03:20 AM
Tony Coles, M.D., Elected To Regeneron (REGN) Board Of Directors 1/31/2017 8:20:25 AM
Indivumed Inc. Announces Agreement With Regeneron (REGN) To Provide Tissue Samples For Oncology Research And Development 1/31/2017 6:52:26 AM
From Tenant to Owner: Cash-Rich Regeneron (REGN) Pays $720 Million for HQ 1/24/2017 7:19:35 AM
Who Might or Might Not Buy Regeneron (REGN), And Why 1/20/2017 5:54:52 AM
What It's Like Working As A Clinical Scientist At Regeneron (REGN) 1/17/2017 4:38:06 PM
Regeneron (REGN) CEO Says Amgen (AMGN) Not Putting Patients First In Patent Dispute 1/10/2017 6:58:53 AM
12345678910...
//-->